Umbra

Umbra biotech

Umbra Biotechnical Corporation

Organization Type/Specialties: Biotech, Genetics, Medical, Bioware, Bio-Warfare
Assets: $286B
Monthly Net Revenue: $12.25B
Employees/Members: 280,000

Societal Position: Dominant, Large Resources, Special Assets (Biotech)
Rank: Corporate, 5/Level, Max 8
Rivals: Aegis Genetics, BioMai, Enyogeni, Rossum

Rank Table
Rank Title Cost
0 Worker, Associate 0
1 Team Leader 5
2 Supervisor 10
3 Local Division Manager 15
4 District Manager 20
5 Division Manager, Director 25
6 Vice President 30
7 Corporate Officer, Member of the Board 35
8 Executive Chairman of the Board 40

Important Facilities

BAD Modifiers

Security: 4
Digital Security: 4
Competence: 5
Knowledge: 3

Description

Umbra Corporation are the world’s largest biotechnology company, with subsiduaries involved in biofuels, wetware, medicine, genetically modified crops, biowarfare and more. Formed from the merger of several of the original biotech pioneers from Europe and North America, it is now a household brand-name.


Umbra

Edgerunners Langy Langy